André Abdo

1.3k total citations
16 papers, 174 citations indexed

About

André Abdo is a scholar working on Genetics, Hematology and Physiology. According to data from OpenAlex, André Abdo has authored 16 papers receiving a total of 174 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Genetics, 6 papers in Hematology and 6 papers in Physiology. Recurrent topics in André Abdo's work include Chronic Lymphocytic Leukemia Research (5 papers), Histiocytic Disorders and Treatments (5 papers) and Chronic Myeloid Leukemia Treatments (5 papers). André Abdo is often cited by papers focused on Chronic Lymphocytic Leukemia Research (5 papers), Histiocytic Disorders and Treatments (5 papers) and Chronic Myeloid Leukemia Treatments (5 papers). André Abdo collaborates with scholars based in Brazil, United States and United Kingdom. André Abdo's co-authors include José Fernando Vilela-Martin, Juan Carlos Yugar‐Toledo, Vanderson Rocha, Frédéric Charlotte, Giancarlo Fatobene, Julien Haroche, Jean‐François Emile, Valérie Taly, Juliana Pereira and Fabiana Roberto Lima and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Neurology.

In The Last Decade

André Abdo

16 papers receiving 171 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
André Abdo Brazil	6	63	56	40	39	28	16	174
Luca Fontanella Italy	9	18 0.3×	76 1.4×	25 0.6×	14 0.4×	5 0.2×	19	348
Stefano Rota Italy	6	38 0.6×	8 0.1×	21 0.5×	16 0.4×	15 0.5×	7	186
Simone Perniola Italy	6	21 0.3×	9 0.2×	9 0.2×	22 0.6×	24 0.9×	24	180
Hiroshige Shimizu Japan	11	95 1.5×	26 0.5×	8 0.2×	6 0.2×	37 1.3×	28	291
Magdalena Martusewicz-Boros Poland	8	149 2.4×	24 0.4×	29 0.7×	7 0.2×	2 0.1×	38	231
Letícia Kawano-Dourado Brazil	9	65 1.0×	14 0.3×	65 1.6×	9 0.2×	5 0.2×	35	254
Joris Ramstein United States	8	240 3.8×	9 0.2×	18 0.5×	18 0.5×	7 0.3×	12	355
Yasutaka Ina Japan	8	199 3.2×	26 0.5×	9 0.2×	10 0.3×	5 0.2×	10	353
Markus Meyer‐Geßner Germany	7	17 0.3×	56 1.0×	8 0.2×	9 0.2×	16 0.6×	13	179
Phuuwadith Wattanachayakul United States	9	19 0.3×	43 0.8×	23 0.6×	8 0.2×	3 0.1×	58	207

Countries citing papers authored by André Abdo

Since Specialization

Citations

This map shows the geographic impact of André Abdo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by André Abdo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites André Abdo more than expected).

Fields of papers citing papers by André Abdo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by André Abdo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by André Abdo. The network helps show where André Abdo may publish in the future.

Co-authorship network of co-authors of André Abdo

This figure shows the co-authorship network connecting the top 25 collaborators of André Abdo. A scholar is included among the top collaborators of André Abdo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with André Abdo. André Abdo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Neves, Precil Diego Miranda de Menezes, et al.. (2024). Overlap of membranous nephropathy and IgA nephropathy in a patient with Kimura’s disease: a case report and literature review. Frontiers in Immunology. 15. 1404954–1404954. 1 indexed citations

Pereira, Juliana, et al.. (2023). Immune reconstitution inflammatory syndrome‐associated lymphoma: A retrospective Brazilian cohort. SHILAP Revista de lepidopterología. 5(1). 147–152. 2 indexed citations

Abdo, André, et al.. (2022). Soluble CD137 as a potential biomarker for severe COVID-19. Immunology Letters. 248. 119–122. 4 indexed citations

Abdo, André, et al.. (2021). MR 4log and low levels of NK cells are associated with higher molecular relapse after imatinib discontinuation: Results of a prospective trial. Leukemia Research. 101. 106516–106516. 4 indexed citations

Nunes, Rafael Amorim Belo, et al.. (2021). Acute myocarditis in a patient with acute promyelocytic leukemia treated with all-trans retinoic acid and idarubicin: a possible relationship with the differentiation syndrome or early anthracycline cardiotoxicity?. Hematology Transfusion and Cell Therapy. 45(1). 127–130. 1 indexed citations

Abdo, André, et al.. (2021). Teaching Video NeuroImages: Multisystemic Erdheim-Chester Disease Presenting as a Cerebellar Ataxia. Neurology. 96(24). e3005–e3006. 1 indexed citations

Bittar, Cristina Salvadori, Stéphanie Itala Rizk, André Abdo, et al.. (2020). Cardiac Tamponade as the First Manifestation of Erdheim-Chester Disease. JACC CardioOncology. 2(2). 324–328. 6 indexed citations

Boquimpani, Carla, et al.. (2020). Inclusion of molecular monitoring (BCR-ABL1) in the treatment of chronic myeloid leukemia in the Brazilian Public Health System (SUS): an urgent need for treatment management. Hematology Transfusion and Cell Therapy. 43(1). 50–57. 2 indexed citations

Fogliatto, Laura, et al.. (2020). Recommendations for the management of cardiovascular risk in patients with chronic myeloid leukemia on tyrosine kinase inhibitors: risk assessment, stratification, treatment and monitoring. Hematology Transfusion and Cell Therapy. 43(2). 191–200. 10 indexed citations

10.

Pagnano, Kátia Bórgia Barbosa, Eliana Miranda, André Abdo, et al.. (2019). Duration of Major Molecular Response and Discontinuation in Deep Molecular Response (MR4.5) Were Associated with Longer Treatment-Free Survival after Imatinib Discontinuation - Results from Two Prospective Brazilian Trials. Blood. 134(Supplement_1). 1655–1655. 5 indexed citations

11.

Fatobene, Giancarlo, Julien Haroche, Frédéric Charlotte, et al.. (2018). BRAF V600E mutation detected in a case of Rosai-Dorfman disease. Haematologica. 103(8). e377–e379. 44 indexed citations

12.

Costa, Isabela Bispo Santos da Silva, André Abdo, Cristina Salvadori Bittar, et al.. (2018). Cardiovascular Manifestations of Erdheim-Chester's Disease: A Case Series. Arquivos Brasileiros de Cardiologia. 111(6). 852–855. 5 indexed citations

13.

Abdo, André, Carla Boquimpani, Alisson L. Matsuo, et al.. (2018). Impact of Treatment Free Remission (TFR) with Nilotinib in 2nd Line for Chronic Myeloid Leukemia on Savings That May Fund All BCR-ABL Tests in the Brazilian Public Healthcare System during and after Nilotinib Treatment. Blood. 132(Supplement 1). 4760–4760. 1 indexed citations

14.

Lima, Fabiana Roberto, et al.. (2016). Diffuse large B-cell lymphoma presenting in the leukemic phase. Autopsy and Case Reports. 6(1). 41–45. 12 indexed citations

15.

Zerbini, Maria Cláudia Nogueira, Mírian Nacagami Sotto, Fernando Peixoto Ferraz de Campos, et al.. (2016). Indeterminate cell histiocytosis successfully treated with phototherapy. Autopsy and Case Reports. 6(2). 33–38. 10 indexed citations

16.

Vilela-Martin, José Fernando, et al.. (2010). Hypertensive crisis: clinical–epidemiological profile. Hypertension Research. 34(3). 367–371. 66 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact